Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Current Deferred Revenue (2016 - 2025)

Adma Biologics (ADMA) has disclosed Current Deferred Revenue for 11 consecutive years, with $143000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Deferred Revenue fell 87.35% year-over-year to $143000.0, compared with a TTM value of $143000.0 through Jun 2025, down 87.35%, and an annual FY2024 reading of $143000.0, down 21.43% over the prior year.
  • Current Deferred Revenue was $143000.0 for Q2 2025 at Adma Biologics, roughly flat from $143000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.1 million in Q2 2024 and bottomed at $142834.0 in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $254074.4, with a median of $142834.0 recorded in 2021.
  • The sharpest move saw Current Deferred Revenue soared 691.13% in 2024, then crashed 87.35% in 2025.
  • Year by year, Current Deferred Revenue stood at $142834.0 in 2021, then rose by 0.12% to $143000.0 in 2022, then increased by 27.27% to $182000.0 in 2023, then decreased by 21.43% to $143000.0 in 2024, then changed by 0.0% to $143000.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for ADMA at $143000.0 in Q2 2025, $143000.0 in Q1 2025, and $143000.0 in Q4 2024.